Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?

• Główni autorzy: Lucia La Sala (Autor), Valentina Carlini (Autor), Caterina Conte (Autor), Maria Belen Macas-Granizo (Autor), Elham Afzalpour (Autor), Jimmy Martin-Delgado (Autor), Marco D'Anzeo (Autor), Roberto F.E. Pedretti (Autor), Angelo Naselli (Autor), Antonio E. Pontiroli (Autor), Riccardo Cappato (Autor)
• Format: Książka
• Wydane: Elsevier, 2024-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Liver and heart disease are major causes of death worldwide. It is known that metabolic alteration causing type 2 diabetes (T2D) and Nonalcoholic fatty liver (NAFLD) coupled with a derangement in lipid homeostasis, may exacerbate hepatic and cardiovascular diseases. Some pharmacological treatments c...